Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

NCT02651220 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT02651220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02651220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
Lead sponsor
Actavis Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2015
Completion date
October 31, 2016
Enrollment
1,001 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acne